http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Thirumurugan Durairaj,Dhamodharan Duraisami,Thanigaivel Sundaram,Vadivalagan Chithravel,Vijayakumar Ramasamy,변헌수 한국화학공학회 2024 Korean Journal of Chemical Engineering Vol.41 No.4
Recent studies have emphasized the application of nanoscience and nanotechnology to disease prevention, diagnosis, and treatment. This study examined the use of marine actinobacteria in the synthesis of silver nanoparticles (AgNPs). UV–Vis spectrophotometry, Fourier infrared spectroscopy, X-ray diff raction, scanning electron microscopy, and energy dispersive X-ray spectroscopy were used to characterize the primary structure, crystalline nature, functional groups, shape, and elemental signal of the synthesized AgNPs. The mean particle diameter of the AgNPs was measured, and the size was found to be between 23 and 27 nm. The antibacterial activity of the AgNPs was evaluated; it showed enhanced inhibitory activity against Escherichia coli , Bacillus subtilis , and Klebsiella pneumoniae . At an AgNP concentration of 40 g/mL, the test pathogen growth was completely inhibited. The larvicidal property of the synthesized AgNPs showed enhanced activity against An. stephensi (LC5017.511 and LC9050.572), A. aegypti (LC50 22.481 and LC90 61.920), and Cx. quinquefasciatus (LC50 29.548 and LC90 73.123). By analyzing the phenotypic data, the 16S rRNA gene sequence, and the phylogenetic data, the probable isolate was also determined to be Streptomyces parvisporogenes KL3. The study results prove that biosynthesized AgNPs can be used as eff ective antibacterial and larvicidal agents in drug formulation.